iotrolan has been researched along with Extravasation of Contrast Media in 3 studies
iotrolan: nonionic, isotonic contrast medium designed for intrathecal use; RN given refers to cpd without isomeric designation; DL-3-117 refers to stereoisomer; structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carmont, MR | 1 |
| Tomlinson, JE | 1 |
| Blundell, C | 1 |
| Davies, MB | 1 |
| Moore, DJ | 1 |
| Wilson, AJ | 1 |
| Evill, CA | 1 |
| Pope, LM | 1 |
| Sage, MR | 1 |
| Brokensha, C | 1 |
| Whitehouse, G | 1 |
1 trial available for iotrolan and Extravasation of Contrast Media
| Article | Year |
|---|---|
A comparison between iotrolan, a non-ionic dimer, and a hyperosmolar contrast medium, Urografin, in hysterosalpingography.
Topics: Adult; Contrast Media; Diatrizoate Meglumine; Double-Blind Method; Extravasation of Diagnostic and T | 1991 |
2 other studies available for iotrolan and Extravasation of Contrast Media
| Article | Year |
|---|---|
Variability of joint communications in the foot and ankle demonstrated by contrast-enhanced diagnostic injections.
Topics: Anesthetics, Local; Cohort Studies; Contrast Media; Extravasation of Diagnostic and Therapeutic Mate | 2009 |
Chemotoxicity testing of nonionic radiographic contrast media against the blood-brain barrier.
Topics: Animals; Arabinose; Blood-Brain Barrier; Contrast Media; Dose-Response Relationship, Drug; Extravasa | 1996 |